| Novartis Pharma Schweiz AG - Travatan, Augentropfen | | 55910 | | 03 | | Travatan | | Augentropfen | | S01EE04 | | Travoprost | | 23.02.2011 | | |
| | Composition | | travoprostum 40 µg, macrogolglyceroli hydroxystearas 2 mg, propylenglycolum, acidum boricum, mannitolum, natrii chloridum, polyquaternium-1, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua purificata q.s. ad solutionem pro 1 ml. | | Packungsbestandteile | | Collyre | | | | | | | | Principe actif | Concentr. |
|---|
| Travoprost | 40 µg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Travoprost | 40 mcg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acide Borique | | | Acidum Hydrochloridum aut Natrii Hydroxidum ad Ph | | | Aqua Purificata | | | Macrogolglyceroli Hydroxystearas | 2 mg/ml | | Mannitol | | | Sodium Chlorure | | | Polyquaternium-1 | | | Propylenglycol | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 2.5 ml | 9.37 | 19.35 | B | LS | Non | | 005 | 3 x 2.5 ml | 26.73 | 45.25 | B | LS | Non |
|
|
